Evogene (Evogene) Price-to-Tangible-Book : (As of Apr. 25, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Evogene Price-to-Tangible-Book?

As of today (2024-04-25), Evogene's share price is $0.6695. Evogene's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $-0.02. Hence, Evogene's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Evogene's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Evogene's highest Price to Tangible Book Ratio was 4.87. The lowest was 1.06. And the median was 1.52.

EVGN's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.67
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Evogene's share price is $0.6695. Evogene's Book Value per Sharefor the quarter that ended in Dec. 2023 was $0.24. Hence, Evogene's P/B Ratio of today is 2.81.

Evogene Price-to-Tangible-Book Historical Data

The historical data trend for Evogene's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evogene Price-to-Tangible-Book Chart

Evogene Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

1.18

5.60

1.76

2.10

Evogene Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															2.10	3.20	71.33	5.81	-

Competitive Comparison of Evogene's Price-to-Tangible-Book

For the Biotechnology subindustry, Evogene's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evogene's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evogene's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Evogene's Price-to-Tangible-Book falls into.

Evogene Price-to-Tangible-Book Calculation

Evogene's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.6695	/	-0.022
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Evogene Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Evogene's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Evogene (Evogene) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evogene Ltd (NAS:EVGN) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

EVGN:Israel

Address

13 Gad Feinstein Street, Park Rehovot, P.O. Box 4173, Ness Ziona, Rehovot, ISR, 7414002

Website

https://www.evogene.com

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment.